Table 4

The HR of CKD in patients with schizophrenia in relation to antipsychotics use during the 3-year follow-up period

VariableNumber of patientsMean years useNumber of CKDIncidence rate*Crude HR
(95% CI)
Adjusted HR†
(95% CI)
TA12990.738622.100.67 (0.47 to 0.94)0.65 (0.46 to 0.92)
 Not used6947737.5911
Amisulpride (days)2430.481610.90
 Not used175014723.6911
 <901230.09821.540.35 (0.08 to 1.45)0.35 (0.08 to 1.45)
 ≥901200.87822.060.54 (0.17 to 1.73)0.55 (0.18 to 1.75)
Aripiprazole (days)1740.4476.73
 Not used181916024.3011
 <901010.08413.370.67 (0.21 to 2.12)0.68 (0.22 to 2.15)
 ≥90730.92313.640.31 (0.04 to 2.19)0.33 (0.04 to 2.33)
Clozapine (days)880.6835.69
 Not used190516023.9711
 <90390.09217.280.59 (0.08 to 4.23)0.58 (0.08 to 4.13)
 ≥90491.1616.7600
Olanzapine (days)3860.53156.50
 Not used160714825.5811
 <901980.08915.260.53 (0.22 to 1.32)0.54 (0.22 to 1.33)
 ≥901880.99610.650.33 (0.10 to 1.06)0.35 (0.11 to 1.11)
Quetiapine (days)4540.584315.76
 Not used153912021.5311
 <902400.082433.551.43 (0.81 to 2.53)1.41 (0.80 to 2.51)
 ≥902141.131929.330.90 (0.43 to 1.87)0.83 (0.40 to 1.74)
Risperidone (days)10660.606410.66
 Not used9279925.1711
 <904760.093222.700.93 (0.56 to 1.52)0.94 (0.57 to 1.53)
 ≥905301.123220.070.59 (0.34 to 1.03)0.59 (0.34 to 1.05)
Zotepine (days)2320.431813.04
 Not used176114523.2011
 <901440.08921.060.98 (0.43 to 2.25)1.02 (0.44 to 2.34)
 ≥90881.00934.281.08 (0.40 to 2.93)1.00 (0.36 to 2.72)
  • 345 patients did not use any antipsychotic.

  • *Incidence rate: per 1000 person-years

  • †Each variable was adjusted for hypertension, diabetes mellitus, hyperlipidaemia and heart disease.

  • ‡p<0.05 for comparison between patients with two groups.

  • TA, typical antipsychotics.